News 26 mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 21 jun 2022 KBI Biopharma and Selexis open a new biologics manufacturing facility in Geneva KBI Biopharma and Selexis, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manu...
News 29 fev 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Actualités 11 jan 2023 Le groupe Bachem décroche un contrat de fourniture de peptides de CHF 1 milliard Le récent contrat d’approvisionnement en peptides du groupe Bachem, d’un montant de CHF 1 milliard et d’une durée de cinq ans, permettra à l’entr...
News 11 out 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
News 20 out 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News 06 set 2023 ten23 health boosts sterile production capacity and introduces new quality control services Renowned for its expertise in sterile drug product manufacturing, Valais-based ten23 health is taking significant steps to expand its services an...
News 13 jun 2023 Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey German pharmaceutical giant Merck has celebrated the inauguration of its state-of-the-art Biotech Development Center in Corsier-sur-Vevey.
ニュース 08 mar 2021 JOI Fes 2020→21に出展 スイスでオープンイノベーションを スイス・ビジネス・ハブ投資促進部は、スイス・イノベーションを代表し、2月26日にオンラインで開催された日本最大級オープンイノベーションカンファレンス「Japan Open Innovation Fes 2021」にブースを出展いたしました。 スイス・イノベーションは、スイス国内に5つのイ...
News 14 mar 2023 CSEM leads the industrialization of HiFiBiO’s complex microfluidic chips HiFiBiO Therapeutics and CSEM are collaborating to create and produce single-cell microfluidics, which have the potential to revolutionize immuno...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 26 jan 2023 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...